Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Short-term Investments: 2017-2025

Historic Short-term Investments for Puma Biotechnology (PBYI) over the last 9 years, with Sep 2025 value amounting to $40.9 million.

  • Puma Biotechnology's Short-term Investments rose 38.70% to $40.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.9 million, marking a year-over-year increase of 38.70%. This contributed to the annual value of $31.7 million for FY2024, which is 179.60% up from last year.
  • According to the latest figures from Q3 2025, Puma Biotechnology's Short-term Investments is $40.9 million, which was down 1.21% from $41.4 million recorded in Q2 2025.
  • Puma Biotechnology's 5-year Short-term Investments high stood at $41.4 million for Q2 2025, and its period low was $3.2 million during Q3 2023.
  • For the 3-year period, Puma Biotechnology's Short-term Investments averaged around $24.8 million, with its median value being $29.7 million (2024).
  • Per our database at Business Quant, Puma Biotechnology's Short-term Investments slumped by 74.32% in 2022 and then skyrocketed by 812.42% in 2024.
  • Quarterly analysis of 5 years shows Puma Biotechnology's Short-term Investments stood at $19.0 million in 2021, then tumbled by 74.32% to $4.9 million in 2022, then spiked by 133.00% to $11.4 million in 2023, then spiked by 179.60% to $31.7 million in 2024, then soared by 38.70% to $40.9 million in 2025.
  • Its Short-term Investments was $40.9 million in Q3 2025, compared to $41.4 million in Q2 2025 and $30.1 million in Q1 2025.